Career advancement of men and women in academic radiology: is the playing field level?

RATIONALE AND OBJECTIVES: The authors' purposes were to determine if there are gender differences in the speed of promotion and/or academic productivity in academic radiology and if this situation had changed since a previous study was performed in 1987. MATERIALS AND METHODS: Surveys were distributed to faculty members of academic radiology departments in May 1997. A total of 707 surveys were analyzed according to gender for time at rank for assistant and associate professor levels, in relation to publication rate, grant funding rate, and distribution of professional time. RESULTS: There was no difference between genders in the time at assistant professor rank. Among all current professors, women had been associate professors longer than men, but there was no difference between genders for those who had been in academic radiology for less than 15 years. There was no gender difference at any rank in the rate of publishing original articles. There was no difference in funding rates, although men had more total grant support. Male associate professors reported spending more time in administration and slightly more time in total hours at work than did their female colleagues, and male professors spent slightly more time teaching residents. Otherwise, there is no difference in how men and women at any rank spend their professional time. There are, however, lower percentages of women in tenured positions and in the uppermost levels of departmental administration. CONCLUSION: The time at rank for men and women and their rate of publication appear to have equalized. Women still are underrepresented at the uppermost levels of departmental administration, however, and are less likely than men to hold tenured positions.

The road to success: factors affecting the speed of promotion of academic radiologists.

RATIONALE AND OBJECTIVES: The authors' purpose was to determine the factors influencing the speed of promotion of academic radiologists. MATERIALS AND METHODS: Three hundred forty-three surveys from faculty members of academic radiology departments with continuous academic careers were analyzed for time in rank at assistant and associate professor levels in relation to publication rate, grant funding rate, and distribution of professional time. Individuals promoted faster than the median time (6 years for assistant professors, 5 years for associate professors) were considered "fast track" and were compared with the remainder of the group. RESULTS: At the assistant professor level, fast track individuals had significantly higher rates of total publications and original articles than did others. At the level of associate professor, fast track individuals had significantly faster rates of publication of original articles, but no significant difference existed in total publication rate. No significant difference was found in the rate of founding of fast track individuals and others. Those with funding were not more likely to be on a fast track than those without funding. Fast track individuals spent significantly more time in administration at the assistant professor level than did other faculty, but no other significant differences were discovered in time distribution at the assistant or associate professor level. CONCLUSIONS: The rate of publishing original articles at the assistant and associate professor levels and the rate of overall publication at the assistant professor level were the most important parameters in predicting speed of promotion.

Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt.

PURPOSE: To assess midterm results and examine factors associated with successful treatment of refractory ascites with creation of a transjugular intrahepatic portosystemic shunt (TIPS). MATERIALS AND METHODS: In 50 patients with refractory ascites, TIPS creation was performed. Clinical and ultrasound follow-up were performed. Success was defined as survival with no further therapeutic paracentesis and decreased ascites. RESULTS: Mean follow-up was 11.6 months after the TIPS procedure. Major complications occurred in 16% of patients including intraperitoneal hemorrhage, refractory encephalopathy, and progression of liver and renal failure. Overall mortality was 60% (30 patients). In 23 (62%) of 37 patients not lost to follow-up, ascites was controlled successfully at 1-3 months. A bilirubin level greater than 3.0 mg/dL (52 mumol/L) and creatinine level greater than 1.9 mg/dL (170 mumol/L) were associated with treatment failure (86% treatment failure at 3 months) and early mortality (P = .03). In all 14 patients alive at 1-year follow-up, ascites was controlled successfully. CONCLUSION: TIPS creation is often useful in treatment of severe ascites not controlled with medical therapy. In patients with advanced liver and renal failure, TIPS creation is not associated with a definite benefit and may hasten death.

Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy.

PURPOSE: To prospectively evaluate the angiographic and clinical results of using catheter-directed thrombolytic therapy for the treatment of acute iliofemoral deep venous thrombosis (IFDVT). MATERIALS AND METHODS: All consecutive patients with acute IFDVT referred for thrombolytic treatment from July 1990 to December 1995 were included in this clinical data analysis. Infusions of urokinase were administered via a multisidehole infusion catheter. Angioplasty, stent placement, mechanical thrombectomy, and other procedures were often performed in conjunction with the thrombolytic procedure. RESULTS: Seventy-seven patients and 87 limbs were treated. The overall technical success rate was 79%, and was 86% for iliac veins and 63% for femoral veins. The primary and secondary patency rates at 1 year were 63% and 78%, respectively, for the iliac veins, and 40% and 51%, respectively, for the femoral veins. Patients with malignant disease fared worse. Patients requiring stent placement appeared to have inferior outcomes. A previous history of DVT did not appear to affect the results. Bleeding requiring transfusion and hematomas were the major complications encountered. Pulmonary embolus was not a significant problem. Technical success rates were lower in patients who had had symptoms for more than 4 weeks compared to those who had a more recent onset of symptoms. CONCLUSION: Current data suggest that catheter-directed thrombolytic therapy is safe and effective in achieving intermediate-term venous Patency. The long-term clinical benefits of this procedure remain, however, to be established.

Changes in tunneled catheter tip position when a patient is upright.

PURPOSE: To determine the relative changes in position of tunneled catheters from supine to upright patient position and factors affecting catheter tip migration. MATERIALS AND METHODS: One hundred forty-six different tunneled catheters were placed through the subclavian or jugular veins radiologically, and catheter positions were documented with use of cine radiography at the time of placement. Follow-up chest radiographs were obtained with the patient in the upright position within 48 hours after placement. Catheter tip positions were numbered from 1 to 8, with 1 representing the innominate/superior vena cava junction and 8, the lower right atrium. Patient sex and weight, the site of catheter entry, and the size and type of catheter were correlated with the relative change in position on the follow-up chest radiogrpahs. RESULTS: There was a statistically significant (P < .0001) change in catheter position on the follow-up chest radiographs, with a mean difference of 1.5 catheter positions (usually mid-right atrium initially to low superior vena cava on follow-up). Catheter tip migration was greater for catheters in the subclavian veins, in females, and in obese patients. CONCLUSIONS: The catheter tip migrates significantly from the initial position at the time of placement as compared to when the patient assumes the upright position. This knowledge is important in achieving the desired final catheter position.

Effect of transjugular intrahepatic portosystemic shunt on quality of life.

OBJECTIVE: The objective of this study was to determine the effect of the transjugular intrahepatic portosystemic shunt (TIPS) procedure on the quality of life. SUBJECTS AND METHODS: Data were collected on 99 patients who underwent the TIPS procedure between September 1991 and September 1995. Quality of life was assessed by the Karnofsky scale before and at intervals after the procedure. Procedure-related complications and other aspects of the patients' overall well-being, as reflected in liver and kidney function and nutritional status, were reviewed immediately before and after TIPS creation. Finally, mortality and TIPS patency rates were tabulated. RESULTS: We observed significantly improved quality of life. The quality of life remained significantly improved throughout the 24-month follow-up period. During the 1- to 3-month interval after the TIPS procedure, we observed in patients a significant decrease in blood urea nitrogen and an increase in albumin and bilirubin. During this period, patients had no significant change in liver enzymes, prothrombin time, ammonia, or creatinine. Complications of the TIPS procedure included a 30% incidence of new or worsened encephalopathy and a 15% incidence of other severe complications (intraperitoneal hemorrhage, severe accelerated liver failure). The procedure-related death rate was 5%. Longer term follow-up showed an overall sustained decrease in blood urea nitrogen, an increase in albumin, and a return of bilirubin to the pre-TIPS levels or below. CONCLUSION: For patients who survive longer than 1 month, TIPS results in an overall, sustained improvement in the quality of life. Improved quality of life may result from a low incidence of repeat variceal bleeding, decreased ascites, and improved nutritional status.

Venous recanalization by metallic stents after failure of balloon angioplasty or surgery: four-year experience.

PURPOSE: This retrospective study describes our updated experience in treating venous stenoses and occlusions with metallic endovascular stents. METHODS: Gianturco, Palmaz, and Wallstent stents were placed in 55 patients over a 4-year period. Stent sites included the subclavian veins (9), innominate veins (3), superior vena cava (4), inferior vena cava (3), iliac veins (29), femoral veins (5), and portal veins (6). The most common indications for stent placement were malignant stenoses and chronic pelvic venous occlusions. Venoplasty and/or urokinase were used as ancillary therapy. Patients were anticoagulated for 3-6 months. Follow-up included clinical assessment and duplex ultrasound. RESULTS: Lifetable analysis shows 59%, 63%, and 72% primary, primary assisted, and secondary 1-year patency rates, respectively. The 4-year primary patency rates were the same. Duration of patency depended on the venous site. Death was a complication of stent placement in 2 patients and 12 patients died within 6 months after stent placement from primary disease progression. Although early failures were more common in stents placed across occlusions than stenoses, 1-year secondary patency rates were comparable. Primary patency rates were only slightly lower in patients with malignant obstruction than in patients with benign disease. CONCLUSION: Endovascular stent placement provides a nonsurgical alternative for reestablishment of venous flow and symptomatic relief in patients with benign as well as malignant venous obstruction.

The mechanisms of positional dysfunction of subclavian venous catheters.

PURPOSE: To determine the origin of subclavian vein catheter and lead dysfunction. MATERIALS AND METHODS: Cineradiography was performed on 10 patients with subclavian venous catheter dysfunction and three patients with pacemaker or defibrillator lead dysfunction. The leads and catheters were removed and replaced with use of a fluoroscopically guided technique; the needle entered the vein lateral to the first rib. Repeat cine examinations were performed following placement of new catheters. RESULTS: The cause of the dysfunction of all 10 catheters was shown to be pinch by the subclavicular musculotendinous tissues as the catheter passed below the clavicle toward its entry into the vein. All three leads were entrapped in the subclavicular tissues and stretched during abduction. The abnormal motion and clinical problems were eliminated after replacement. CONCLUSION: Subclavian catheter and lead malfunction is not due to compression between the first rib and the clavicle. It is due to entrapment in the subclavius muscle-costoclavicular ligament complex, which binds or compresses the device during movements. These problems can be avoided by employing fluoroscopically guided puncture techniques that enter the vein lateral to the first rib.

Iliofemoral venous stenoses: effectiveness of treatment with metallic endovascular stents.

PURPOSE: To assess effectiveness of metallic endovascular stents in treatment of venous stenoses and occlusions. MATERIALS AND METHODS: Stents were placed intravenously in 56 patients (59 stenoses or occlusions) over a 6-year period. Stent sites included the inferior vena cava (n = 10) and common iliac (n = 31), external iliac (n = 46), common femoral (n = 27), and superficial femoral veins (n = 4). Indications for stent placement included stenoses from pelvic malignancy and its treatment; trauma, surgery, or pregnancy; and idiopathic stenoses. Patients underwent anticoagulation therapy for 3-6 months after stent placement. Follow-up was performed with duplex ultrasound. RESULTS: With use of life-table analysis, overall primary and secondary 1-year patency rates were 50% and 81%, respectively. Primary and secondary 4-year patency rates were and 50% and 75%, respectively. Five patients died of primary disease progression within 6 months after stent placement. Major complications occurred in 6.8% of cases. One-year secondary patency rates were statistically significantly lower (P = .05) for patients with malignant disease, although primary patency rates were comparable. Overall sustained decrease in symptoms (P < .0001) was observed 1 year later. CONCLUSION: Endovascular stent placement is a nonsurgical alternative for reestablishment of venous flow and sustained relief of symptoms in patients with malignant or benign pelvic venous disease.

Color Doppler sonography of the thoracic inlet veins.

Color duplex sonography of the thoracic inlet veins produces a spectrum of normal and abnormal findings. These vessels include the internal jugular, innominate, subclavian, and axillary veins. Although venography is the traditional means of imaging these veins, ultrasound lends itself to assessment of these vessels by providing anatomic and hemodynamic information. Advances in gray-scale resolution and color Doppler technology permit direct visualization of thrombus, stenosis, collateral vessels, catheters, and stents, as well as sensitive spectral waveform analysis. Abnormal findings in the thoracic inlet veins include locally elevated velocities at stenoses with low velocities peripherally. Thrombus, extrinsic compression, and collateral vessels may also produce abnormal findings. Common interpretive pitfalls are caused by transducer pressure, deep inspiration, slow flow, collateral veins, large-bore catheters, and hemodialysis fistulas. A thorough knowledge of the regional anatomy, normal and abnormal waveforms, and commonly encountered pitfalls will optimize the accuracy of color duplex sonography of the thoracic inlet veins.

Applications of the Amplatz snare device during interventional radiologic procedures.

The Amplatz gooseneck snare (Microvena, St. Paul, MN) is a recently developed device for the percutaneous removal of intravascular foreign bodies [1-5] (Fig. 1). In the past several years, various other applications of this snare system have been devised for placing, replacing, repositioning, or removing guidewires, catheters, and other devices during interventional procedures. The Amplatz gooseneck snare, which has been described [1], comes in a variety of loop sizes and is provided with either 4- or 6-French guiding catheters, although substitution with any of several soft, blunt-tipped guiding catheters is possible [5]. The principal advantage of the Amplatz snare over past systems is that the loop is at a right angle to the catheter, easing the capture of foreign bodies, devices, or catheters.

Duplex sonography after transjugular intrahepatic portosystemic shunts (TIPS): normal hemodynamic findings and efficacy in predicting shunt patency and stenosis.

OBJECTIVE: Portal hemodynamics are altered by placement of a transjugular intrahepatic portosystemic shunt (TIPS). Normal duplex sonographic findings after TIPS placement and hemodynamic alterations indicating shunt failure have not yet been well described. The purposes of this study were to determine normal hemodynamic changes on duplex sonography after TIPS placement and to assess the efficacy of duplex sonography in detecting shunt dysfunction. SUBJECTS AND METHODS: Forty patients underwent TIPS placement and were entered into a study that included routine sonographic evaluation and portal venography at regular intervals. Portal venography was also performed if shunt velocities on duplex sonography changed from the baseline, which raised the question of shunt stenosis or occlusion. The pre-TIPS duplex sonographic study included determination of patency, velocity, and flow direction in the main, right, and left portal veins and in the hepatic artery. Follow-up sonography included the pre-TIPS examination in addition to velocity determinations in three segments of the shunt. Correlation was made between 82 concurrent sonographic and portal venographic studies. RESULTS: High-velocity blood flow (mean peak velocity, 135-200 cm/sec) was consistently seen within patent, well-functioning shunts. Hepatic artery peak systolic velocities increased from 79 cm/sec before TIPS placement to 131 cm/sec after TIPS placement (p < .001). Main portal vein velocities increased from 21.8 cm/sec before TIPS placement to 41.5 cm/sec after TIPS placement (p < .001). When compared with portal venography, duplex sonography was 98% sensitive and 100% specific in predicting the presence of blood flow within the stent. Sonography was highly sensitive and specific for detecting stent stenosis. Final sonographic criteria for shunt stenosis in angiographically documented cases were low-velocity shunt flow (< or = 60 cm/sec) in the entire stent, or low-velocity shunt flow with an associated focal velocity elevation. CONCLUSION: Consistent changes in portal venous and hepatic arterial hemodynamics are normally seen on duplex sonography after placement of a TIPS. Duplex sonography accurately predicts shunt patency and dysfunction when compared with portal venography. Duplex sonography is an effective, noninvasive method of evaluating shunt function and should be considered for use as the primary imaging technique in routine follow-up after TIPS placement.

Management of pelvic venous stenosis with intravascular stainless steel stents.

Patients with gynecologic malignancies may develop stenosis of the large pelvic veins as a result of their disease or its treatment. The percutaneous insertion of a stainless steel vascular stent is a novel approach to the management of an extrinsically compressed vein. The objective of this study was to review the results of treating lower extremity edema secondary to a pelvic venous stenosis through the percutaneous insertion of a stainless steel vascular stent. A retrospective review was performed on gynecologic oncology patients who presented with an edematous lower extremity and underwent an evaluation to diagnose proximal venous stenosis. The evaluation included sonography, venography, and balloon angioplasty prior to the percutaneous insertion of a stainless steel vascular stent. If a venous thrombosis was documented, thrombolysis with urokinase was performed prior to evaluation for venous stenosis. Records were reviewed for the etiology of the venous stenosis, the location and type of stent inserted, and the ability of the stent to maintain patency and provide symptomatic relief. Patency was evaluated at 1-week and then at 1-, 3-, and 6-month intervals. The probability of vascular stent patency was calculated using life table analysis. Ten patients with cervical (n = 4), corpus (n = 3), ovarian (n = 1), vulvar (n = 1), and vaginal (n = 1) cancer had one or more vascular stents inserted for the treatment of a stenosed pelvic vein. The etiologies of venous stenosis were radiation fibrosis and surgery (n = 5), postoperative fibrosis (n = 3), and metastatic tumor (n = 2). The stented vessels were the left common (n = 5) or left external (n = 4) iliac veins, the right common (n = 1) or right external (n = 3) iliac veins, and the right common femoral vein (n = 1). The median follow-up was 21 months. All patients had subjective resolution of their edematous extremity while the stents were patent. The interval probability of patency of stented veins was greater than 85% at each evaluation interval. Patency was 100% for patients beyond 6 months of follow-up. There were no major complications. The percutaneous intravascular insertion of a stainless steel stent was safe and subjectively effective in the management of venous stenosis associated with a gynecologic cancer. A prospective trial with objective endpoints may be warranted.

Mechanical thrombectomy with the Amplatz device: human experience.

PURPOSE: The authors present their early experience of mechanical arterial and graft thrombectomy with the Amplatz thrombectomy device. PATIENTS AND METHODS: Preliminary data are presented for 14 patients treated with the Amplatz thrombectomy catheter. The procedure was carried out in 10 arterial polytetrafluorethylene grafts, in two native arteries, and in two patients with venous thrombosis. RESULTS: The thrombectomy catheter completely removed the clot in 11 patients and partially removed clot in three patients. Mean thrombectomy time was 2 minutes 45 seconds. Despite distal blood pressure cuff occlusion, two instances of insignificant distal embolization occurred. Mechanical clot dissolution has consistently produced hemolysis without adverse clinical effects. The underlying causative factors such as stenoses were treated by means of angioplasty, atherectomy, or surgical endarterectomy. CONCLUSION: Mechanical thrombectomy with this device is a new, effective technique and can rapidly remove the thrombus. From preliminary results, the device seems most promising in clearing out thrombi in occluded synthetic femoral-to-popliteal bypass grafts. The device could have wider application if it were steerable and if it could be introduced from the contralateral approach.

Development of stenoses in transjugular intrahepatic portosystemic shunts.

PURPOSE: To evaluate the frequency and significance of stenoses or occlusions developing within transjugular intrahepatic portosystemic shunts (TIPS) and identify predictive factors. MATERIALS AND METHODS: Medical records of 52 patients who underwent TIPS placement between September 1991 and October 1993 were reviewed. Various shunt parameters were correlated with the development of shunt abnormalities. Findings at follow-up portography and frequency of variceal bleeding and paracentesis were also noted. RESULTS: Twenty-four patients were followed up for at least 6 months. In eight patients, stenoses developed within 6 months; one shunt occluded. No clear correlations were found between shunt parameters and development of shunt abnormalities. Two of four patients with recurrent variceal bleeding had associated shunt abnormalities. The frequency of stenosis of TIPS was high. CONCLUSION: Early detection and prompt revision of stenotic shunts may decrease the frequency of recurrent variceal bleeding and ascites.

In vitro and in vivo experimental evaluation of a new vena caval filter.

PURPOSE: A new stainless steel (MP35N alloy) vena cava filter without a central stasis point was evaluated in vitro and in vivo. MATERIALS AND METHODS: The clot-trapping efficiency and hemodynamic flow pattern of the filter were assessed in a flow model and were compared with those of currently available commercial filters including the Vena Tech-LGM, Simon nitinol, Greenfield, and Bird's Nest filters. The new filter was placed in the inferior vena cava (IVC) of 31 dogs; 21 of the 31 dogs were followed up with cavography for up to 3 months. At the termination of the study, the filters and IVCs were examined grossly and histologically. An in vivo clot-trapping test was carried out in five dogs. RESULTS: The least turbulence was noted with the new filter and the titanium Greenfield filter. The stainless steel Greenfield and Simon nitinol filters caused major flow disturbances. Migration within 5 cm of initial placement occurred in two animals (9.5%). There were no IVC thromboses, perforations, or filter embolizations. An in vivo clot-trapping study showed an 80% efficiency for small thrombi (3 x 20 mm) and 100% efficiency for large thrombi (6 x 20 mm) with the new filter. The Simon and the new filter had the best clot-trapping capabilities. The Vena Tech-LGM and Bird's Nest filters were slightly inferior and the Greenfield filter demonstrated by far the lowest trapping capacity. CONCLUSION: The new vena cava filter is easily introduced percutaneously through a 12-F sheath and appears to be very promising due to its high filtering capability, low turbulence, nonmagnetic properties, good mechanical stability, and hypothrombogenicity. Clinical trials are warranted.